Endometrial transitional cell carcinoma

MONDO:0002832

A rare primary carcinoma of the endometrium characterized by the presence of malignant epithelial cells resembling urothelial transitional cells. The malignant transitional cells constitute at least 90% of the tumor cells.

Also known as: endometrial transitional cell carcinoma

2857 clinical trials for this condition and its sub-types, 1 tagged with Endometrial transitional cell carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Transitional cell carcinoma (724) ↑ Endometrial carcinoma (316)

Including sub-types (2857) Tagged with Endometrial transitional cell carcinoma (1)

Not yet finished but already full! 1

Immunotherapy duo takes on rare tumors

Disease control Ongoing

This phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Endometrial transitional cell carcinoma

Where it sits in the disease tree

Immunotherapy duo takes on rare tumors